Brief: Guerbet Says OptiVantage Multi-Use Injector Is Now CE-Marked
Nov 23 (Reuters) - GUERBET SA GRBT.PA :
* OPTIVANTAGE MULTI-USE INJECTOR IS NOW CE-MARKED.
* OPTIVANTAGE®MULTI-USE WILL INITIALLY BE MARKETED IN EMEA
FROM
JANUARY 2019,
Source text: https://bit.ly/2TCYbKC
Further company coverage: GRBT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Revenue At 30 September 2026 Of EUR 573.8 Million
Corrected: French medical imaging firm Guerbet's 9M revenue slips on China sales drop
French medical imaging firm Guerbet H1 EBITDA margin falls on Raleigh site costs
Brief: Guerbet H1 EBITDA €30.6 Mln
French and Benelux stocks-Factors to watch